Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Dec 31, 2025 → Mar 31, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ASTRAZENECA PLC | 0 | 875 | 875 | 1.62% | $172.57K |
| ROIVANT SCIENCES LTD | 0 | 5,450 | 5,450 | 1.41% | $150.96K |
| COGENT BIOSCIENCES INC | 0 | 2,770 | 2,770 | 1.00% | $106.62K |
| APOGEE THERAPEUTICS INC | 0 | 962 | 962 | 0.76% | $80.97K |
| PRAXIS PRECISION MEDICINES INC | 0 | 167 | 167 | 0.50% | $53.81K |
| ZAR/USD FORWARD | 0 | 24,466 | 24,466 | 0.23% | $24.47K |
| NOVO NORDISK CVR | 0 | 1,848 | 1,848 | 0.00% | $0 |
| SANOFI SA - CVR | 0 | 940 | 940 | 0.00% | $0 |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ASTRAZENECA PLC SPONS ADR | 2,838 | 0 | -2,838 | 0.00% | -$260.90K |
| EXACT SCIENCES CORP | 2,043 | 0 | -2,043 | 0.00% | -$207.49K |
| AVIDITY BIOSCIENCES | 2,143 | 0 | -2,143 | 0.00% | -$154.57K |
| Roivant Sciences Ltd. | 6,565 | 0 | -6,565 | 0.00% | -$142.46K |
| CIDARA THERAPEUTICS INC | 534 | 0 | -534 | 0.00% | -$117.96K |
| U.S. Secured Overnight Financing Rate | 54,372 | 0 | -54,372 | 0.00% | -$54.37K |
| NOVO NORDISK A/S-CVR | 1,848 | 0 | -1,848 | 0.00% | $0 |
| Sanofi SA, Escrow Account | 940 | 0 | -940 | 0.00% | $0 |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| INSMED INC | 1,564 | 1,616 | 52 | 2.48% | -$7.95K |
| BEONE MEDICINES LTD ADR | 794 | 829 | 35 | 2.31% | $4.96K |
| ARGENX SE SPONSORED ADR | 199 | 236 | 37 | 1.61% | $4.99K |
| MEDPACE HOLDINGS INC | 246 | 282 | 36 | 1.27% | -$2.75K |
| APELLIS PHARMACEUTICALS INC | 3,138 | 3,277 | 139 | 1.24% | $53.01K |
| ARROWHEAD PHARMACEUTICALS INC | 2,021 | 2,102 | 81 | 1.23% | -$2.38K |
| CRISPR THERAPEUTICS AG | 2,539 | 2,555 | 16 | 1.14% | -$11.60K |
| AXSOME THERAPEUTICS INC | 638 | 651 | 13 | 1.03% | -$6.49K |
| Ascendis Pharma A/S | 394 | 476 | 82 | 1.02% | $24.86K |
| ARCELLX INC | 800 | 928 | 128 | 1.00% | $54.39K |
| SCHOLAR ROCK HOLDING CORP | 2,016 | 2,063 | 47 | 0.95% | $12.61K |
| MADRIGAL PHARMACEUTICALS INC | 176 | 186 | 10 | 0.91% | -$5.13K |
| MIRUM PHARMACEUTICALS INC | 914 | 1,043 | 129 | 0.90% | $24.16K |
| RHYTHM PHARMACEUTICALS INC | 892 | 969 | 77 | 0.79% | -$11.21K |
| SUMMIT THERAPEUTICS INC | 3,619 | 3,923 | 304 | 0.70% | $11.08K |
| NUVALENT INC-A | 675 | 722 | 47 | 0.69% | $6.07K |
| TRAVERE THERAPEUTICS INC | 2,373 | 2,412 | 39 | 0.67% | -$19.01K |
| ARCUTIS BIOTHERAPEUTICS INC | 2,919 | 2,943 | 24 | 0.65% | -$15.43K |
| VERACYTE INC | 2,079 | 2,127 | 48 | 0.64% | -$19.02K |
| ULTRAGENYX PHARMA INC | 2,391 | 2,714 | 323 | 0.53% | $1.87K |
| GRAIL INC | 483 | 1,023 | 540 | 0.50% | $11.53K |
| SOLENO THERAPEUTICS INC | 1,529 | 1,567 | 38 | 0.49% | -$18.33K |
| RECURSION PHARMACEUTICALS INC | 16,064 | 16,655 | 591 | 0.48% | -$14.57K |
| ADMA BIOLOGICS INC | 5,070 | 5,232 | 162 | 0.44% | -$45.34K |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ABBVIE INC | 3,864 | 3,661 | -203 | 7.46% | -$86.65K |
| AMGEN INC | 1,777 | 1,602 | -175 | 5.28% | -$17.97K |
| GILEAD SCIENCES INC | 4,288 | 3,830 | -458 | 5.00% | $7.48K |
| VERTEX PHARMACEUTICALS INC | 1,141 | 966 | -175 | 4.04% | -$85.93K |
| REGENERON PHARMACEUTICALS INC | 554 | 496 | -58 | 3.59% | -$44.39K |
| ALNYLAM PHARMACEUTICALS INC | 855 | 848 | -7 | 2.63% | -$59.41K |
| NATERA INC | 1,161 | 1,128 | -33 | 2.11% | -$40.38K |
| UNITED THERAPEUTICS CORP DEL | 445 | 376 | -69 | 2.09% | $6.13K |
| BIOGEN INC | 1,392 | 1,180 | -212 | 2.03% | -$28.65K |
| ROYALTY PHARMA PLC | 5,545 | 4,443 | -1,102 | 2.00% | -$1.13K |
| ILLUMINA INC | 1,584 | 1,519 | -65 | 1.75% | -$20.53K |
| REVOLUTION MEDICINES INC | 2,298 | 1,871 | -427 | 1.70% | -$1.08K |
| MODERNA INC | 5,264 | 3,493 | -1,771 | 1.66% | $22.21K |
| INCYTE CORP | 1,971 | 1,779 | -192 | 1.57% | -$27.24K |
| VIATRIS INC | 15,141 | 11,963 | -3,178 | 1.51% | -$26.89K |
| BRIDGEBIO PHARMA INC | 2,281 | 2,134 | -147 | 1.48% | -$16.00K |
| ALKERMES PLC | 4,661 | 4,470 | -191 | 1.48% | $27.64K |
| JAZZ PHARMA PLC | 923 | 833 | -90 | 1.48% | $569 |
| NEUROCRINE BIOSCIENCES INC | 1,216 | 1,158 | -58 | 1.43% | -$19.91K |
| GUARDANT HEALTH INC | 1,673 | 1,643 | -30 | 1.42% | -$19.12K |
| IONIS PHARMACEUTICALS INC | 2,119 | 1,983 | -136 | 1.39% | -$18.73K |
| EXELIXIS INC | 3,765 | 3,237 | -528 | 1.30% | -$26.19K |
| BIOMARIN PHARMACEUTICAL INC | 2,857 | 2,371 | -486 | 1.25% | -$35.85K |
| CYTOKINETICS INC | 2,143 | 1,921 | -222 | 1.19% | -$9.55K |
| VAXCYTE INC | 2,543 | 2,103 | -440 | 1.14% | $4.87K |
| HALOZYME THERAPEUTICS INC | 2,082 | 1,811 | -271 | 1.10% | -$23.07K |
| BIONTECH SE ADR | 1,365 | 1,288 | -77 | 1.07% | -$15.47K |
| TG THERAPEUTICS INC | 3,220 | 3,127 | -93 | 0.97% | $7.89K |
| PTC THERAPEUTICS INC | 1,537 | 1,509 | -28 | 0.96% | -$13.94K |
| PROTAGONIST THERAPEUTICS INC | 1,226 | 893 | -333 | 0.88% | -$12.96K |
| AMICUS THERAPEUTICS INC | 8,407 | 6,081 | -2,326 | 0.82% | -$31.78K |
| KYMERA THERAPEUTICS INC | 953 | 929 | -24 | 0.72% | $3.22K |
| TWIST BIOSCIENCE CORP | 2,065 | 1,599 | -466 | 0.71% | $10.48K |
| VIKING THERAPEUTICS INC | 2,576 | 2,334 | -242 | 0.71% | -$14.68K |
| ACADIA PHARMACEUTICALS INC | 3,293 | 3,242 | -51 | 0.68% | -$15.79K |
| SAREPTA THERAPEUTICS INC | 3,296 | 3,207 | -89 | 0.65% | -$1.15K |
| CELCUITY INC | 721 | 611 | -110 | 0.65% | -$2.17K |
| LIQUIDIA TECHNOLOGIES INC | 2,123 | 1,765 | -358 | 0.62% | -$6.61K |
| BEAM THERAPEUTICS INC | 2,727 | 2,543 | -184 | 0.57% | -$14.99K |
| KRYSTAL BIOTECH INC | 256 | 197 | -59 | 0.48% | -$12.23K |
| INTELLIA THERAPEUTICS INC | 5,203 | 3,943 | -1,260 | 0.47% | $3.77K |
| LEGEND BIOTECH CORP SPON ADR | 4,285 | 2,794 | -1,491 | 0.47% | -$42.61K |
| ZAR/USD FORWARD | 54,372 | 26,922 | -27,450 | 0.25% | -$27.45K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.